Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes.

about

Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes.

Item

http://www.wikidata.org/entity/Q52641285

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes.

@en

Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes.

@nl

type

Item

label

Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes.

@en

Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes.

@nl

prefLabel

Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes.

@en

Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes.

@nl

P1476

Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes.

@en

P2093

He-Juan Hu

http://www.w3.org/2001/XMLSchema#string

Jin-Zhong Huang

http://www.w3.org/2001/XMLSchema#string

Xianhong Li

http://www.w3.org/2001/XMLSchema#string

Xiying Tang

http://www.w3.org/2001/XMLSchema#string

Yingqi Chen

http://www.w3.org/2001/XMLSchema#string

Yunyi Yao

http://www.w3.org/2001/XMLSchema#string

P2860

Dysfunctions of neuronal and glial intermediate filaments in disease

Mitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based Therapies

Glia as drivers of abnormal neuronal activity

Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease

Mechanisms of U87 astrocytoma cell uptake and trafficking of monomeric versus protofibril Alzheimer's disease amyloid-β proteins

Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.

Redox-active iron mediates amyloid-beta toxicity.

Mitochondrial ATP synthase: architecture, function and pathology.

Treatment of human astrocytoma U87 cells with silicon dioxide nanoparticles lowers their survival and alters their expression of mitochondrial and cell signaling proteins.

Developing pharmacological therapies for Alzheimer disease.

P304

6997-7004

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2018.8761

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29568933

http://www.w3.org/2001/XMLSchema#string

P921

astrocyte

P932

5928648

http://www.w3.org/2001/XMLSchema#string